Allyn C Howlett

Q: What Schools Are Affiliated With Allyn C Howlett

Allyn C Howlett is affiliated with the following schools: Rutgers University, Wake Forest University, Jawaharlal Nehru University, Pennsylvania State University, North Carolina Central University

Allyn C Howlett's AcademicInfluence.com Rankings

Allyn C Howlett

Medical

#2480

World Rank

#2907

Historical Rank

Pharmacology

#257

World Rank

#303

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Allyn C Howlett Influential?

(Suggest an Edit or Addition)

Interviews with Allyn Howlett

(See a Problem?)

Allyn C Howlett's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors (2002) (2552)
Determination and characterization of a cannabinoid receptor in rat brain. (1988) (2256)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (2010) (1504)
Cannabinoid physiology and pharmacology: 30 years of progress (2004) (614)
Pharmacology of cannabinoid receptors. (1995) (496)
Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. (1986) (478)
Cannabinoid receptor signaling. (2005) (422)
Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. (1984) (367)
Reconstitution of hormone-sensitive adenylate cyclase activity with resolved components of the enzyme. (1978) (339)
The cannabinoid receptors. (2002) (329)
The cannabinoid receptor: biochemical, anatomical and behavioral characterization (1990) (305)
Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains (1994) (268)
Early phytocannabinoid chemistry to endocannabinoids and beyond (2014) (264)
Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. (1985) (259)
Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. (1988) (252)
Cellular signal transduction by anandamide and 2-arachidonoylglycerol. (2000) (234)
Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. (1997) (220)
Cannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain (1990) (216)
CB(1) cannabinoid receptors and their associated proteins. (2010) (211)
Inhibitors of arachidonoyl ethanolamide hydrolysis. (1994) (194)
The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. (1995) (160)
Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. (1984) (147)
CB1 and CB2 Receptor Pharmacology. (2017) (147)
Chemically Distinct Ligands Promote Differential CB1 Cannabinoid Receptor-Gi Protein Interactions (2005) (144)
Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. (1993) (135)
Stereochemical effects of 11-OH-Δ 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor (1990) (121)
Endocannabinoid tone versus constitutive activity of cannabinoid receptors (2011) (121)
CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a (2007) (120)
The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. (2000) (109)
Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid. (1994) (108)
Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. (2002) (107)
The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome. (2013) (105)
Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum (2001) (104)
Thujone Exhibits Low Affinity for Cannabinoid Receptors But Fails to Evoke Cannabimimetic Responses (1999) (101)
Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor. (2000) (101)
Cannabinoid inhibition of adenylate cyclase: Relative activity of constituents and metabolites of marihuana (1987) (89)
Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates (2001) (88)
Reconstitution of catecholamine-sensitive adenylate cyclase. Association of a regulatory component of the enzyme with membranes containing the catalytic protein and beta-adrenergic receptors. (1979) (87)
Homology model of the CB1 cannabinoid receptor: Sites critical for nonclassical cannabinoid agonist interaction (2003) (87)
Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies. (1998) (87)
Signal transduction via cannabinoid receptors. (2009) (86)
Efficacy in CB1 receptor‐mediated signal transduction (2004) (79)
CB1 receptor–G protein association (2001) (79)
Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs. (1988) (78)
The Cannabinoid Receptor (2019) (76)
Adenylyl Cyclase, a Coincidence Detector for Nitric Oxide* (1999) (76)
Zinc Inhibition of cAMP Signaling* (2002) (71)
The CB1Cannabinoid Receptor in the Brain (1998) (70)
CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. (2002) (69)
Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor. (2002) (68)
Rat brain cannabinoid receptors are N-linked glycosylated proteins. (1995) (67)
Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists. (1998) (66)
CB 1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1 a (2007) (58)
Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis. (1998) (57)
CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains. (2001) (56)
Helix 8 Leu in the CB1 Cannabinoid Receptor Contributes to Selective Signal Transduction Mechanisms* (2007) (56)
Regulation of Gi by the CB1 cannabinoid receptor C-terminal juxtamembrane region: structural requirements determined by peptide analysis. (1999) (53)
CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells. (1998) (52)
The Endocannabinoid System and Oligodendrocytes in Health and Disease (2018) (52)
Hydrodynamic properties of the regulatory component of adenylate cyclase. (1980) (51)
Lipopolysaccharide and cyclic AMP regulation of CB2 cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages (2006) (50)
Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity. (1995) (50)
Anandamide-Mediated CB1/CB2 Cannabinoid Receptor-Independent Nitric Oxide Production in Rabbit Aortic Endothelial Cells (2007) (50)
Nitric oxide selectively inhibits adenylyl cyclase isoforms 5 and 6. (2000) (48)
Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation (2015) (48)
An Assessment of the Role of Opioid Receptors in the Response to Cannabimimetic Drugs (1986) (47)
Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity (2000) (46)
Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils. (1999) (46)
Failure of cannabinoid compounds to stimulate estrogen receptors. (1997) (45)
Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis. (1998) (45)
Amphetamine Self-Administration Attenuates Dopamine D2 Autoreceptor Function (2014) (45)
Vasoactive intestinal polypeptide induces tyrosine hydroxylase in PC12 cells. (1991) (43)
The cannabinoid receptor: Biochemical and cellular properties in neuroblastoma cells (1991) (41)
Nitric oxide, an endogenous regulator of Dictyostelium discoideum differentiation. (1997) (40)
Efficiency of coupling between the beta adrenergic receptor and adenylate cyclase. (1978) (39)
Localization of cannabinoid receptors in brain (1988) (39)
Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors. (1996) (39)
Chronic exposure toΔ9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors (1991) (39)
Vasoactive Intestinal Polypeptide‐Related Peptides Modulate Tyrosine Hydroxylase Gene Expression in PC12 Cells Through Multiple Adenylate Cyclase‐Coupled Receptors (1993) (38)
Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells (2008) (38)
Ca2+ ‐Dependent Release from Rat Brain of Cannabinoid Receptor Binding Activity (1992) (36)
CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function (2016) (36)
Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies. (1989) (35)
Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins. (1993) (35)
Effect of environmental estrogens on IL-1β promoter activity in a macrophage cell line (1998) (35)
Cannabinoid Regulation of Nitric Oxide Synthase I (nNOS) in Neuronal Cells (2009) (34)
CB1 receptors modulate the intake of a sweetened-fat diet in response to mu-opioid receptor stimulation of the nucleus accumbens (2010) (33)
Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites (2017) (32)
Signal transduction of eicosanoid CB1 receptor ligands. (1999) (32)
5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. (1992) (30)
Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells. (2015) (30)
D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates. (2000) (29)
Nitric oxide regulation of glyceraldehyde-3-phosphate dehydrogenase activity in Dictyostelium discoideum cells and lysates. (1994) (28)
Aminoalkylindoles (AAIs): a new route to the cannabinoid receptor? (1990) (28)
WIN55212-2 Docking to the CB1 Cannabinoid Receptor and Multiple Pathways for Conformational Induction (2006) (28)
Secretin Receptors on Neuroblastoma Cell Membranes: Characterization of 125I‐Labeled Secretin Binding and Association with Adenylate Cyclase (1984) (27)
CB₁ cannabinoid receptors promote maximal FAK catalytic activity by stimulating cooperative signaling between receptor tyrosine kinases and integrins in neuronal cells. (2013) (27)
Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats (2014) (27)
Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization. (1994) (26)
Dopaminergic regulation of dopamine release from PC12 cells via a pertussis toxin-sensitive G protein (1991) (25)
Ca(2+) mobilization through dorsal root ganglion Ca(2+)-sensing receptor stably expressed in HEK293 cells. (2007) (25)
Nitric oxide‐releasing compounds inhibit Dictyostelium discoideum aggregation without altering cGMP production (1992) (25)
Synthesis and release of Vasoactive Intestinal Polypeptide (VIP) by mouse neuroblastoma cells: Modulation by cyclic nucleotides and ascorbic acid (1985) (24)
Increased Angiotensin II Contraction of the Uterine Artery at Early Gestation in a Transgenic Model of Hypertensive Pregnancy Is Reduced by Inhibition of Endocannabinoid Hydrolysis (2014) (23)
Nitric oxide stimulates the ADP-ribosylation of a 41-kDa cytosolic protein in Dictyostelium discoideum. (1992) (22)
Drama-based education to motivate participation in substance abuse prevention (2007) (21)
Effects of nitric oxide on adenylyl cyclase stimulation in N18TG2 neuroblastoma cells. (1998) (21)
(Aminoalkyl)indole isothiocyanates as potential electrophilic affinity ligands for the brain cannabinoid receptor. (1996) (21)
Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups. (1998) (20)
Unique helical conformation of the fourth cytoplasmic loop of the CB1 cannabinoid receptor in a negatively charged environment. (2007) (19)
Stimulation of neuroblastoma adenylate cyclase by arachidonic acid metabolites. (1982) (19)
Azido‐ and Isothiocyanato‐Substituted Aryl Pyrazoles Bind Covalently to the CB1 Cannabinoid Receptor and Impair Signal Transduction (2000) (19)
Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure (2019) (18)
A short guide to the nomenclature of seven-transmembrane spanning receptors for lipid mediators. (2005) (17)
Complete artificial saliva alters expression of proinflammatory cytokines in human dermal fibroblasts (2012) (16)
Hormone-sensitive adenylate cyclase: resolution and reconstitution of some components necessary for regulation of the enzyme. (1978) (16)
CB1 knockout mice display significant changes in striatal opioid peptide and D4 dopamine receptor gene expression (2006) (16)
Regulation of Dictyostelium discoideum adenylate cyclase by manganese and adenosine analogs. (1987) (15)
Reverse pharmacology applied to the cannabinoid receptor. (1990) (15)
RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells (2016) (15)
The Regulation of Vasoactive Intestinal Peptide Synthesis in Neuroblastoma and Chromaffin Cells a (1988) (14)
Nitric oxide inhibits the initiation of cAMP pulsing in D. discoideum without altering receptor-activated adenylate cyclase. (1996) (14)
Molecular Mechanism and Cannabinoid Pharmacology. (2020) (14)
Glucocorticoids plus opioids up-regulate genes that influence neuronal function (2007) (14)
Hippocampal Gαq/11 but not Gαo-coupled receptors are altered in aging (2013) (14)
Steric Trigger as a Mechanism for CB1 Cannabinoid Receptor Activation (2004) (13)
Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity (2017) (13)
Pertussis and cholera toxin ADP-ribosylation in Dictyostelium discoideum membranes. (1987) (13)
Binding mode prediction of conformationally restricted anandamide analogs within the CB1 receptor (2008) (13)
Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation. (2000) (13)
Classical and nonclassical cannabinoids: mechanism of action--brain binding. (1990) (12)
Nitric oxide regulates adenylyl cyclase activity in rat striatal membranes (2001) (12)
Chronic baclofen desensitizes GABAB-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain (2015) (12)
Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex (2008) (11)
Regulation of nicotine-evoked dopamine release from PC12 cells. (1991) (11)
Endocannabinoids and Reactive Nitrogen and Oxygen Species in Neuropathologies (2006) (11)
Ammonium sulfate modifies adenylate cyclase and the chemotactic receptor of Dictyostelium discoideum. Evidence for a G protein effect. (1987) (10)
CB1 Cannabinoid Receptors Stimulate Gβγ-GRK2-Mediated FAK Phosphorylation at Tyrosine 925 to Regulate ERK Activation Involving Neuronal Focal Adhesions (2020) (10)
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression (2016) (10)
Cannabinoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (10)
Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease (2020) (9)
Regulation of gene expression by tobacco product preparations in cultured human dermal fibroblasts. (2014) (9)
Mouse Neuroblastoma CB1 Cannabinoid Receptor-Stimulated [35S]GTPɣS Binding: Total and Antibody-Targeted Gα Protein-Specific Scintillation Proximity Assays. (2017) (8)
Involvement of a pertussis toxin-sensitive G protein in the regulation of angiotensinogen production by an angiotensin II analog in HepG2 cells. (1990) (8)
Endocannabinoid System in Pregnancy Maintenance and Labor: A Mini-Review (2021) (8)
Cannabinoid Receptors and Signal Transduction (2013) (8)
The cannabinoid receptor-pharmacologic identification, anatomical localization and cloning. (1992) (7)
Unified Pharmacophoric Model for Cannabinoids and Aminoalkylindoles Derived from Molecular Superimposition of CB1Cannabinoid Receptor Agonists CP55244 and WIN55212-2 (1999) (7)
Structural studies leading to the discovery of a cannabinoid binding site. (1988) (7)
Thyroid effects on adenosine 3',5'-monophosphate levels and adenylate cyclase in cultured neuroblastoma cells. (1987) (7)
In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b) - CB1 cannabinoid receptor. (2017) (7)
Pharmacology of Cannabis (1998) (6)
Systemic Blockade of the CB1 Receptor Augments Hippocampal Gene Expression Involved in Synaptic Plasticity but Perturbs Hippocampus-Dependent Learning Task. (2019) (6)
Cannabinoid receptors: pharmacology, second messenger systems and endogenous ligands. (1994) (6)
Cyclic nucleotide phosphodiesterase isozymes in neuroblastoma cells (1987) (6)
Muscarinic receptor binding is inhibited by quinacrine (1991) (6)
CB1 & CB2 Receptor Pharmacology (2018) (6)
CB1 cannabinoid receptor‐phosphorylated fourth intracellular loop structure‐function relationships (2018) (6)
The Spicy Story of Cannabimimetic Indoles (2021) (6)
Reward, control & decision-making in cannabis use disorder: insights from functional MRI. (2019) (6)
Cannabinoid Receptor-Gi Protein Interactions (2005) (6)
Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity (2015) (6)
Endogenous ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase that is not regulated by nitric oxide in Dictyostelium discoideum. (1993) (5)
Mechanical properties of lower limb dermis following static and cyclic compression. (2012) (5)
Muscarinic pharmacology of the inhibition of adenylate cyclase in N18TG2 neuroblastoma cells (1987) (5)
Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism. (2005) (5)
Cannabinoid Agonist and Inverse Agonist Regulation of G Protein Coupling (2009) (4)
Anandamide-Mediated CB 1 / CB 2 Cannabinoid Receptor-Independent Nitric Oxide Production in Rabbit Aortic Endothelial Cells (2007) (4)
Cannabinoid Receptor Interacting Protein ( CRIP ) 1 a competition with β-arrestin for CB 1 receptor binding sites (2016) (4)
Cannabinoid action in the central nervous system. (1988) (4)
Functional Selectivity at Receptors for Cannabinoids and Other Lipids (2009) (3)
Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b) (2019) (3)
Inhibition of adenylate cyclase by p-bromophenacyl bromide. (1991) (3)
Gαi/o-dependent Ca2+ mobilization and Gαq-dependent PKCα regulation of Ca2+-sensing receptor-mediated responses in N18TG2 neuroblastoma cells (2015) (3)
WIN55212‐2 Docking to the CB1 Cannabinoid Receptor and Multiple Pathways for Conformational Induction. (2006) (3)
Effects of 35 kHz, low-frequency ultrasound application in vitro on human fibroblast morphology and migration patterns. (2015) (2)
Cannabinoid receptor subtype influence on neuritogenesis in human SH-SY5Y cells (2020) (2)
Unified Pharmacophoric Model for Cannabinoids and Aminoalkylindoles (2000) (2)
Differential Expression of CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Protein 1a in Labor. (2021) (2)
Regulation of adenylate cyclase in a cultured neuronal cell line by marijuana constituents, metabolites of delta-9-tetrahydrocannabinol, and synthetic analogs having psychoactivity. (1987) (2)
Guanine nucleotide inhibition of adenylate cyclase in a membrane fraction from Dictyostelium discoideum. (1985) (2)
Identification and partial characterization of some components of hormone-stimulated adenylate cyclase. (1979) (1)
Nucleus accumbens and food intake 1 CB 1 receptors modulate the intake of a sweetened fat diet in response to mu-opioid receptor stimulation of the nucleus accumbens (2013) (1)
Metabotropic glutamate 2,3 receptor stimulation desensitizes agonist activation of G‐protein signaling and alters transcription regulators in mesocorticolimbic brain regions (2020) (1)
S49 lymphoma wild type and variant clones contain normal calcium dependent regulator. (1978) (1)
Abstract 182: Medullary Endocannabinoid Content Contributes to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression (2013) (1)
Aminoalkyl)indole Isothiocyanates as Potential Electrophilic Affinity Ligands for the Brain Cannabinoid Receptor. (1996) (1)
Functional characterization of cannabinoid receptor‐interacting protein CRIP1a (2013) (1)
Blockade of CB1 receptors reveals that elevated medullary endocannabinoids contribute to age‐related impairment of baroreflex sensitivity in Sprague‐Dawley rats (681.4) (2014) (1)
Molecular Interactions of Cannabinoid Receptor Interacting Protein 1 A and B with Cannabinoid Receptor 1 (2017) (1)
Solubilization of the Cannabinoid Receptor from Rat Brain Membranes a (1992) (1)
Cannabinoid receptor interacting protein 1a interacts with myristoylated Gαi N terminus via a unique gapped β-barrel structure (2021) (1)
Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects (2014) (1)
Conformational Characterization of Phosphorylated Analogs of a Peptide Mimetic of the Fourth Cytoplasmic Loop of CB1Cannabinoid Receptor (2013) (0)
Effects of NaCl concentration on adenylate cyclase regulation by prostaglandins and guanine nucleotides. (1982) (0)
Giα and β Proteins Associate in a Complex with Cannabinoid Receptor Interacting Protein 1a (CRIP1a) (2022) (0)
Chronic phenmetrazine treatment promotes D2 dopaminergic and α2-adrenergic receptor desensitization and alters phosphorylation of signaling proteins and local cerebral glucose metabolism in the rat brain (2021) (0)
902: CB1 cannabinoid receptor and cannabinoid receptor interacting protein in human myometrium and placenta during labor (2020) (0)
Discovery of a cannabinoid receptor in rat brain (1988) (0)
High-Voltage-Activated Calcium Currents in Cannabinoids Modulate the P-Type (2015) (0)
288 INVOLVEMENT OF CANNABINOID RECEPTOR TYPE 2 IN MICTURITION IN MICE (2013) (0)
P049. Cannabinoid-mediated nitric oxide signal transduction in N18TG2 neuronal cells (2006) (0)
Abstract 542: Blockade of Angiotensin-(1-7)-mediated Vascular Remodeling by a CB2 Cannabinoid Receptor Antagonist (2014) (0)
Atorvastatin differentially regulates the interactions of cocaine and amphetamine with dopamine transporters (2022) (0)
Modulation of Cannabinoid Receptor Interacting Protein 1a (CRIP1a) Expression Using Adeno‐Associated Virus and Effects on Striatal Neuropharmacology and Neuronal Cells in Culture (2010) (0)
Phosphorylation of CB1Cannabinoid Receptor Fourth Intracellular Loop Peptides: Effects on Structure and Function (2016) (0)
Effects of Nitric Oxide on Adenylyl Cyclase Stimulation in N 18 TG 2 Neuroblastoma Cells 1 (1998) (0)
WIN55212-2 Modulates Intracellular Calcium via CB1 Receptor-Dependent and Independent Mechanisms in Neuroblastoma Cells (2022) (0)
DIFFERENTIAL EXPRESSION OF CB1 CANNABINOID RECEPTOR AND CANNABINOID RECEPTOR INTERACTING PROTEIN 1A IN LABOR (2020) (0)
Investigating potential cardiotoxicity of JWH-073 (2017) (0)
Glucocorticoids plus opioids upregulate genes that influence synaptic plasticity (2006) (0)
Design, synthesis, and evaluation of substituted alkylindoles that activate G protein-coupled receptors distinct from the cannabinoid CB1 and CB2 receptors. (2023) (0)
Catecholamine-Sensitive Adenylate Cyclase: Identification and Partial Characterization of Some of its Components* (1979) (0)
Abstract 465: The CB2 Cannabinoid Receptor Mediates the Anti-Proliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle Cells (2013) (0)
Structure and Function of Cannabinoid Receptor Interacting Protein 1a (CRIP1a) (2021) (0)
CB1 Cannabinoid Receptor Juxtamembrane C‐terminal Phosphorylation in NT18TG2 Cells (2013) (0)
Abstract 183: Chronic Systemic CB1 Cannabinoid Receptor Blockade Reduces Blood Pressure and Weight Gain and Improves Baroreflex Function and Heart Rate Variability in Hypertensive (mRen2)27 Rats (2013) (0)
CB1 BUT NOT CB2 CANNABINOID RECEPTOR INCREASES NEURITE EXTENSION IN HUMAN NEUROBLASTOMA (2018) (0)
CB1 Cannabinoid Receptors Signal Through Focal Adhesion Kinase To Activate ERK In Neuronal Cells (2013) (0)
[16-OR]: Vasoactive lipid mediators control uterine vascular reactivity at early pregnancy in the transgenic hAGNxhREN rat (2015) (0)
Cannabinoid receptor antagonists and G protein subtypes (2019) (0)
Crystal Structure of the Cannabinoid Receptor 1 Interacting Protein 1a (CRIP1a) (2021) (0)
544 ROLE OF CANNABINOID AND TRPV1 RECEPTORS IN THE SPINAL MECHANISMS OF MICTURITION IN THE NORMAL RAT (2013) (0)
Phosphorylation of CB1 Cannabinoid Receptor Fourth Intracellular Loop pepducins: Effects on Structure and Function (2016) (0)
Solution Structure of a peptide mimetic of the fourth cytoplasmic loop of the G-protein coupled CB1 cannabinoid receptor (2006) (0)
Cannabinoid Receptor Agonists and Antagonists (1995) (0)
Substance Abuse Knowledge and Prevention Survey (2014) (0)
Cannabinoid receptors in the brain and cultured neuroblastoma cells (1990) (0)
Aryl pyrazole Ligands as CB1 carinabinoid antagonists (2002) (0)
Structural Analysis of CRIP1a by in Silico Approaches (2014) (0)
Differential blood pressure response in normotensive rats and rats with angiotensin II‐dependent hypertension following systemic cannabinoid CB1 receptor blockade (1140.11) (2014) (0)
Cannabinoid Receptor Interacting Protein 1a (CRIP1a) regulates CB1 signaling and transcriptional activity (2012) (0)
Abstract 117: Contribution of Endocannabinoids via CB1 Receptors to the Impaired Baroreflex Sensitivity in (mRen2)27 Transgenic Hypertensive Rats (2012) (0)
Regulation of adenylate cyclase of Dictyostelium discoideum by divalent cations and adenosine analogs (1986) (0)
G-protein alpha subtypes in human and rabbit erythrocytes exist as monomers and high molecular weight complexes (2000) (0)
Chronic baclofen treatment influences GABAB activation of G‐proteins and phosphorylation of FAK, GSK3β, and DARPP32 in mesocorticolimbic rat brain regions (1066.3) (2014) (0)
CB1 Cannabinoid Receptor Location and CRIP1a (2011) (0)
The CB1 cannabinoid receptor‐mediated inhibition of cAMP accumulation in neuroblastoma cells: role of different Gi/o protein subtypes (2020) (0)
Abstract P189: Angiotensin II - Endocannabinoid Interactions in the Nucleus of the Solitary Tract are Important for Regulation of Baroreflex Control of Heart Rate (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Allyn C Howlett?

Allyn C Howlett is affiliated with the following schools: